First Meeting of the Parties to the Cartegena Biosafety Protocol

 
The Independent Science Panel (ISP) is a panel of scientists from many disciplines, committed to the Promotion of Science for the Public Good. Read our statement here

ISP members Drs. Susan Bardocz, Mae-Wan Ho and Arpad Pusztai attended the First Meeting of the Parties to the Cartagena Biosafety Protocol, 22 - 27 February 2003 held in Kuala Lumpur, Malaysia.

They spoke at major side events, gave numerous interviews to journalists and independent film makers, took part in an hour-long TV program, and provided informal advice to ngos and government delegates.

It was time well-spent, as they lent much needed support to the overwhelming majority of countries wanting a strong Biosafety Protocol.

Dr Mae-wan Ho : "The inherent risks of GMOs are so huge that talking about compliance and liability is almost an absurdity and surreal."
 

A RENOWNED critic of the biotech industry said the questionable technology used by scientists on genetically modified organisms (GMOs) needs to be addressed urgently before talks on biosafety standards could go on.

Dr Mae-wan Ho, founder and director of the Institute of Science in Society (ISIS) in Britain, said delegates to the first meeting of the Cartagena Protocol on Biosafety (CPB) should decide on a moratorium of further field testings of GMOs.

“Pro-GM scientists should only be allowed to continue with their research in the laboratory and not turn the whole world into their open laboratory and subject everyone to the risks. Let scientists do more research in a contained environment instead of rushing to commercialise their products,” says Ho.

She says all intended release should be banned until the pro-GM scientists could address the transgenic line instability that had surfaced in commercially-approved GM crops that had been tested so far.

Viewed as a critical fundamental issue on biosafety concerning GM crops, Ho says the transgenic process is uncontrollable and once a GM gene is introduced into an organism, there is absolutely no control over how it might behave as shown by the tests conducted last year by French government scientists on five commercial varieties of GM crops: Monsanto’s MON810 maize, Roundup-Ready soya, GA21 Maize, Bayer’s T15 maize and Syngenta’s Bt 176 maize.

 

 
 

Ho says in practically every case, transgenic inserts (introduced GM genes) were found to have rearranged themselves not just from the construct used but also from their structure in the transgenic line reported by the companies.

(A GMO is created by joining together new combinations of DNA from widely different sources and deliberately inserting the artificial constructs into the genomes of the intended organisms.

"I have pressed for ‘event specific’ molecular characterisation of the structure of the inserts and their position in the genome in successive generations, as proof that the transgenic line is stable,” adding that she would suggest five successive generations of observation.

She also pointed out that the promoter widely used by the biotech industry is highly hazardous. The cauliflower mosaic virus (CaMV) 35S promoter has a recombination hotspot, resulting in fragmentation and rearrangement of the transgenic DNA which in turn increases transgenic instability.

The CaMV 35S promoter fulfills the role of a very aggressive promoter in forcing a foreign gene to express in an organism, but such viral transgenes in plant could recombine with naturally occurring viruses to generate, in some cases, super-infectious viruses.

“(In my opinion) the protocol is like a big bad joke on real people. The inherent risks of GMOs are so huge that talking about compliance and liability is almost an absurdity and surreal,” she says in reference to the on-going meeting of the CPB that is deliberating on biosafety standards to be adopted in response to the emergence of GMOs.

The CPB is intended to be an international legal framework designed to deal with the specific hazards of genetic engineering recognised by the international community through the Convention on Biological Diversity.

“There are outstanding safety concerns regarding GM crops which have yet to be addressed. Drastic things can happen. In Mexico, for example, strains of GM crops are contaminating local maize varieties, raising concern that it may destabilise the genome of these conventional maize even when there is no known cultivation of GM crops there,” she adds.

Furthermore, she said compliance is not only a tricky issue but is also unjust.

“Developing countries have no capacity for monitoring compliance. In any case, why should they pay for this mess? They didn’t create these monsters. Irresponsible scientists from developed countries created this so the responsibility should lie on industrialised nations to clean up the mess,” she says, adding that scientists should be conscious of their role in society.

Developing counties made up the majority of the parties to the CPB, while GMO-exporting countries like the United States and Canada have stayed out and are actively lobbying behind the scene to weaken the standards.

She says the priority of the scientific research community is misplaced and a revitalisation of indigenous knowledge that promotes conservation of biodiversity and development of sustainable alternative is the much needed paradigm shift for the future of mankind.

Dr Ho, a senior research fellow at the Open University in England, specialises in human biochemical genetics and is a well-known figure in the debate on genetic engineering and biosafety.

   

 

 

 
www.indsp.org Web
www.i-sis.org.uk
e-mail:[email protected]
 

© 2003 Independent Science Panel